Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Amyloidosis × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 328 Carcinoma, Non-Small-Cell Lung 163 Neoplasms 93 Breast Neoplasms 90 Lung Neoplasms 76 Urinary Bladder Neoplasms 68 Neoplasm Metastasis 62 Ovarian Neoplasms 47 Lymphoma 35 Cholangiocarcinoma 34 Sarcoma 32 Gallbladder Neoplasms 30 Biliary Tract Neoplasms 30 Hodgkin Disease 27 Adenocarcinoma 26 Lymphoma, Non-Hodgkin 24 Lymphoma, Large B-Cell, Diffuse 22 Unspecified Adult Solid Tumor, Protocol Specific 21 Fallopian Tube Neoplasms 21 Colorectal Neoplasms 21 Bile Duct Neoplasms 20 Urethral Neoplasms 19 Triple Negative Breast Neoplasms 19 Carcinoma, Transitional Cell 18 Carcinoma, Ovarian Epithelial 18 Recurrence 17 Carcinoma 17 Adenocarcinoma of Lung 15 Small Cell Lung Carcinoma 13 Carcinoma, Renal Cell 13

Interventions

Dexamethasone 10 Melphalan 7 Calcium Dobesilate 5 Lenalidomide 4 Bortezomib 4 miridesap 3 Cyclophosphamide 3 ixazomib 2 Doxycycline 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Thalidomide 1 Tacrolimus 1 Pharmaceutical Preparations 1 Interleukin-2 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Etanercept 1 Drug Evaluation 1 Blood Specimen Collection 1 Biopsy 1 Antilymphocyte Serum 1 ARQ 197 1 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02791373 2018-04-03

ViGeM

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡